PEGylation Reagents for Drug Delivery

Article

Gelest, a manufacturer and provider of silane, silicone, and metal-organic compounds, released a range of dual-function poly(ethylene glycol) (PEG) reagents that enable new approaches to PEGylation for bioconjugates.

Gelest, a manufacturer and provider of silane, silicone, and metal-organic compounds, released a range of dual-function poly(ethylene glycol) (PEG) reagents that enable new approaches to PEGylation for bioconjugates, reduction of surface biofouling, and formation of polymerizeable vesicles for drug transport.

These materials are heterobifunctional with an amine at one terminus, and a choice of two different species at the other terminus. One species can undergo radical reactions, and the second species can undergo hydrolytic condensation.

In addition to reacting directly with appropriate functionality of drug or protein substrates, these materials have the potential to undergo polymerization, and to form polymerizeable vesicles, stabilizing PEGylated drugs or acting as co-monomers for microencapsulated drug delivery. The polymerization can proceed by either free-radical organic polymerization or hydrolysis-condensation siloxane polymerization.

Source: Gelest

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Related Content
© 2025 MJH Life Sciences

All rights reserved.